Waters Expands CORTECS Analytical Column Portfolio
November 10 2016 - 9:00AM
Business Wire
New Liquid Chromatography Columns Allow
Scientists to Fine Tune Their Chromatographic Separations and
Maintain Maximum Performance
Waters Corporation (NYSE:WAT) today expanded its CORTECS®
Columns product line with the introduction of two new chemistries:
Waters® CORTECS T3 and CORTECS Shield RP18. These new CORTECS
column chemistries allow scientists to obtain more information per
analysis and reduce the cost of analyzing complex samples such as
biomarkers, natural products, counterfeit cosmetics, synthetic
cannabinoids, veterinary drugs, drinking water, and vitamins.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20161110005272/en/
Waters Corporation introduces two new
column chemistries: Waters® CORTECS T3 and CORTECS Shield RP18
allowing scientists to obtain more information per analysis and
reduce the cost of analyzing complex samples. (Photo: Business
Wire)
“Today’s scientists want more tools for improving the
resolution, speed, selectivity, and sensitivity of their UPLC,
UHPLC, and HPLC separations,” said Doug McCabe, Director of Product
Management - Consumables Group. “CORTECS Columns deliver the
batch-to-batch reproducibility, robustness, and quality that
customers have come to expect from Waters.”
When used with an ultra-low dispersion ACQUITY UPLC® instrument
platform, the CORTECS UPLC 1.6 micron particle columns are designed
to deliver approximately 40% greater increase in separations
efficiency when compared to fully porous particles of an equivalent
particle size. The highly-efficient CORTECS 2.7 micron particle
columns are for use on both the ACQUITY Arc™ UHPLC system and the
Waters Alliance® HPLC system and operate at lower backpressures
allowing for the use of longer column lengths to improve resolution
or shorten analysis times and increase throughput.
The CORTECS T3 and CORTECS Shield RP18 chemistries compliment
the currently available CORTECS C18+, C18, C8, Phenyl, and HILIC
chemistries. All CORTECS chemistries are fully scalable between the
1.6 micron and 2.7 micron particle sizes. The CORTECS T3 and
CORTECS Shield RP18 chemistries are offered in 48 unique column
configurations and are immediately available for shipping
worldwide.
It’s All in the Chemistry
With different particle characteristics and innovative charged
surface modifications, CORTECS Columns are suitable for use in a
wide variety of applications.
CORTECS T3 columns provide balanced retention for polar and
non-polar molecules when run under reversed-phase LC conditions.
The increased pore diameter (120Å vs. 90Å) along with the lower C18
ligand density and proprietary end capping enables the CORTECS T3
chemistry to operate in 100% aqueous mobile phase without the fear
of the phase dewetting.
Shield RP18 columns utilize an embedded carbamate functional
group into the alkyl ligand which provides alternative selectivity
for basic and polyphenolic compounds when compared to typically
bonded C18 phases. The embedded polar carbamate groups act as
hydrogen bond acceptors, and provide unique selectivity especially
for basic and polyphenolic compounds.
For more information: www.waters.com/cortecs
About Waters Corporation
(www.waters.com)
Waters Corporation (NYSE:WAT) develops and manufactures advanced
analytical and material science technologies for laboratory
dependent organizations. For more than 50 years, the company has
pioneered a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis
systems.
Waters, ACQUITY, ACQUITY UPLC, ACQUITY Arc, Alliance,
UltraPerformance LC, UPLC and CORTECS are trademarks of Waters
Corporation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161110005272/en/
Waters CorporationBrian J. Murphy, 508-482-2614Public
Relationsbrian_j_murphy@waters.com
Waters (NYSE:WAT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Waters (NYSE:WAT)
Historical Stock Chart
From Sep 2023 to Sep 2024